Insider · CIK 0001888039
John Merris
Files at SBDS (Solo Brands, Inc.). First filing Dec 19, 2022, latest Dec 19, 2022.
In brief
John Merris files SEC Form 4 as CEO, president and director at SBDS (Solo Brands, Inc.). Since Dec 19, 2022, John Merris has reported 1 open-market buy worth $21k and 0 open-market sells worth $0, the latest filed on Dec 19, 2022.
A track record needs three past buys with six months of prices behind them; John Merris has 0, so none is measured yet.
The newest scored trade: bought $21k of SBDS on Dec 16, 2022, filed Dec 19, 2022, scored 43 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SBDS: Solo Brands, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | SBDSbuy Solo Brands, Inc. | $21k 5,533 shares | +4% | +4% from low-77% from high |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | SBDS Solo Brands, Inc. | MOption exercise Class A Common Stock | +1,766 | $0.00 | $0 | 182,803 | Jan 4, 2024 |
| Jan 4, 2024 | SBDS Solo Brands, Inc. | FTax withholding Class A Common Stock | -523 | $6.16 | $3,222 | 182,280 | Jan 4, 2024 |
| Jan 4, 2024 | SBDS Solo Brands, Inc. | MOption exercise Restricted Stock Unitderivative | -1,766 | $0.00 | $0 | 19,429 | Jan 4, 2024 |
| Nov 9, 2023 | SBDS Solo Brands, Inc. | MOption exercise Class A Common Stock | +4,596 | $0.00 | $0 | 182,156 | Nov 13, 2023 |
| Nov 9, 2023 | SBDS Solo Brands, Inc. | FTax withholding Class A Common Stock | -1,119 | $4.53 | $5,069 | 181,037 | Nov 13, 2023 |
| Nov 9, 2023 | SBDS Solo Brands, Inc. | MOption exercise Restricted Stock Unitsderivative | -4,596 | $0.00 | $0 | 36,764 | Nov 13, 2023 |
| Dec 16, 2022 | SBDS Solo Brands, Inc. | POpen-market purchase Class A Common Stock | +1,133 | $3.81 | $4,317 | 140,152 | Dec 19, 2022 |
| Dec 16, 2022 | SBDS Solo Brands, Inc. | POpen-market purchase Class A Common Stock | +1,950 | $3.82 | $7,449 | 142,102 | Dec 19, 2022 |
| Dec 16, 2022 | SBDS Solo Brands, Inc. | POpen-market purchase Class A Common Stock | +2,150 | $3.83 | $8,235 | 144,252 | Dec 19, 2022 |
| Dec 16, 2022 | SBDS Solo Brands, Inc. | POpen-market purchase Class A Common Stock | +100 | $3.84 | $384 | 144,352 | Dec 19, 2022 |
| Dec 16, 2022 | SBDS Solo Brands, Inc. | POpen-market purchase Class A Common Stock | +200 | $3.84 | $768 | 144,552 | Dec 19, 2022 |
| Nov 18, 2022 | SBDS Solo Brands, Inc. | MOption exercise Class A Common Stock | +18,383 | $0.00 | $0 | 136,509 | Nov 21, 2022 |
| Nov 18, 2022 | SBDS Solo Brands, Inc. | FTax withholding Class A Common Stock | -4,476 | $4.49 | $20k | 132,033 | Nov 21, 2022 |
| Nov 18, 2022 | SBDS Solo Brands, Inc. | MOption exercise Restricted Stock Unitderivative | -18,383 | $0.00 | $0 | 55,146 | Nov 21, 2022 |
Questions about John Merris
Answered from the filings on this page, as of the latest one.
Is John Merris buying or selling?
Not in the last 12 months. John Merris's latest open-market trade on SEC Form 4 was bought $21k of SBDS on Dec 16, 2022.
How did John Merris's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Merris has 0.
Where does John Merris file Form 4?
John Merris has filed Form 4 at SBDS (Solo Brands, Inc.) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.